Tobacco industry conflicts of interest cannot go undeclared in scientific publishing

Funding

TL and ABG's time is supported by Bloomberg Philanthropies, as part of the Bloomberg Initiative to Reduce Tobacco Use. ABG's time is also supported by UK Research and Innovation funding for the Commercial Determinants of Health and Equity Consortium (grant number MR/Y030753/1), which is part of Population Health Improvement UK, a national research network which works to transform health and reduce inequalities through change at the population level. ABG has received a grant from SPECTRUM (UK Prevention Research Partnership); has received support for speaking at the Society for Research on Nicotine or Tobacco's annual meeting; has received travel funds to speak at events organised by El Poder del Consumidor and The Intersectoral Prevention Laboratory Centre for Clinical Research and Prevention; is an unpaid member of the Royal College of Physicians Tobacco Advisory Group, the Council of ASH, and the WHO International Expert Group on the Commercial Determinants of Health; and is an unpaid European Editor of Tobacco Control. No funders had a role in the investigation or writing of this Correspondence, nor in the decision to submit it for publication.